Active Ingredient: TERBINAFINE HYDROCHLORIDE
Proprietary Name: LAMISIL
Dosage Form; Route of Administration: CREAM; TOPICAL
Strength: 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N020192
Product Number: 001
Approval Date: Dec 30, 1992
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status:
Discontinued
Patent and Exclusivity Information